CAS: 4113-12-6; 1-(Hexadecyloxy)Hexadecane

相似化合物

629-82-3 4542-57-8 2456-28-2

上下游产品

1-十六烷醇 1-Hexadecanol 36653-82-4
棕榈酸乙酯 Ethyl Palmitate 628-97-7

📜1-十六烷醇置于tin (II) Sulfate体系中,化学反应生成 十六烷醚
参考文献:Oddo,Gazzetta Chimica Italiana,1901,Vol. 31 I,P. 340
标题:Oddo,Gazzetta Chimica Italiana,1901,Vol. 31 I,P. 340

专利信息

专利号:US-2012190064-A1
优先权日:2004-10-01
标题 :Feeding buffers, systems, and methods for in vitro synthesis of biomolecules
发明人：KUDLICKI WIESLAW ANTONI; KEPPETIPOLA SHIRANTHI; FLETCHER JULIA; GETBEHEAD ASHLEY ELAINE; KATZEN FEDERICO; VOZZA-BROWN LAURA
权利人:KUDLICKI WIESLAW ANTONI; KEPPETIPOLA SHIRANTHI; FLETCHER JULIA; GETBEHEAD ASHLEY ELAINE; KATZEN FEDERICO; VOZZA-BROWN LAURA; LIFE TECHNOLOGIES CORP
摘要:Compositions, methods and kits for in vitro systems for synthesis of biomolecules such as polypeptides, are provided herein. Cell extracts that provide enhanced yields of soluble proteins using in vitro protein synthesis methods are provided. The invention also includes methods for producing high yields of proteins by the addition of a feeding solution that includes amino acids and an energy source to an ongoing in vitro synthesis system. The invention also includes methods of using a high-yield in vitro synthesis system to produce large quantities of proteins with incorporated labeled amino acids for analysis by methods such as by NMR. The invention further includes vectors for enhanced production of proteins from nucleic acid templates using in vitro synthesis systems.

专利号:US-8932545-B2
优先权日:2008-10-20
标 题:Synthesis of metal compounds
发明人：MEPSTED GARY OWEN; EWEKA EMMANUEL IMASUEN
权利人:MEPSTED GARY OWEN; EWEKA EMMANUEL IMASUEN; QINETIQ LTD
摘要:A method is provided for the synthesis of a mesoporous lithium transition metal compound, the method comprising the steps of (i) reacting a lithium salt with one or more transition metal salts in the presence of a surfactant, the surfactant being present in an amount sufficient to form a liquid crystal phase in the reaction mixture (ii) heating the reaction mixture so as to form a sol-gel and (iii) removing the surfactant to leave a mesoporous product. The mesoporous product can be an oxide, a phosphate, a borate or a silicate and optionally, an additional phosphate, borate or silicate reagent can be added at step (i). The reaction mixture can comprise an optional chelating agent and preferably, the reaction conditions at steps (i) and (ii) are controlled so as to prevent destabilization of the liquid crystal phase. The invention is particularly suitable for producing mesoporous lithium cobalt oxide and lithium iron phosphate. The method can be used to synthesize mesoporous lithium cobalt oxide having a specific surface area in excess of 10 m 2 /g, preferably 15 m 2 /g or more.

专利号:US-4913852-A
优先权日:1986-06-24
标题 :Compounds obtained from the associative synthesis of sulfur-containing or sulfur-free amino acids with pregnane derivatives
发明人：MILIONI CATHERINE; EFTHYIMIOPOULOS CONSTANTIN; KOCH BERNARD; JUNG LOUIS; JUNG JEAN
权利人:MILIONI CATHERINE; EFTHYIMIOPOULOS CONSTANTIN; KOCH BERNARD; JUNG LOUIS; JUNG JEAN
摘要:Compounds obtained from the associative synthesis of sulfur-containing or sulfur-free amino acids with derivatives of Δ-4-pregnene-3,20-dione or with derivatives of Δ-1,4-pregnadiene-3,20-dione of the general formulas (I), (II) and (III), having glucocorticoidal and anti-inflammatory properties have been prepared and tested. Pharmaceutical compositions, medicaments containing them as well as their applications are claimed, particularly in the cutaneous and ophthalmic fields. ##STR1##

专利号:WO-2007094746-A1
优先权日:2006-02-16
标 题 :5,7-dimethyladamantane-1,3-dicarboxylic acid dialkyl esters, a method for the synthesis thereof and method for synthesising a 5,7-dimethyladamantane-1,3-dicarboxylic acid in the form of an intermediate product
发明人：GOLOVKO LEONID VLADIMIROVICH; PILJAVSKY VOLODIMIR STEPANOVIC; BOYKO OLEKSANDR POLIKARPOVICH; KHILCHEVSKYY OLEKSANDR MIKOLAY; PETRENKO OLEKSANDR EVGRAFOVICH
权利人:GOLOVKO LEONID VLADIMIROVICH; PILJAVSKY VOLODIMIR STEPANOVIC; BOYKO OLEKSANDR POLIKARPOVICH; KHILCHEVSKYY OLEKSANDR MIKOLAY; PETRENKO OLEKSANDR EVGRAFOVICH
摘要:5,7-dimethyladamantane-1,3-dicarboxylic acid dialkyl esters of general formula (I), wherein R is C4 - C30 alkyl. Method for synthesis of said dialkyl esters consists in synthesising 5,7- dimethyladamantane-1,3-dicarboxylic acid chloride, alcoholising said chloride by aliphatic alcohol in a boiling benzene or toluene, removing a solvent and in purifying a target product. Method for synthesising 5,7-dimethyladamantane-1,3-dicarboxylic acid in the form of an intermediate product consists in synthesising perhydroacenaphthene by acenaphthene hydrogenation, isomerizating perhydroacenaphthene into 1,3-dimethyladamantane in the presence of AICI3, in synthesising 1,3-dimethyl-5,7-dibromoadamantane by two- stage bromation of 1,3-dimethyladamantane in such a way that a monobromoderivative thereof is obtained at the first stage, is subsequently converting it into 1,3-dimethyl-5,7-dibromoadamantane at the second stage and in carboxylating said compound by formic acid in the presence of 10-20% oleum.

专利号:US-6869973-B2
优先权日:2000-06-22
标题:Nitrosated and nitrosylated taxanes, compositions and methods of use
发明人：GARVEY DAVID S; LETTS L GORDON; LIN CHIA-EN; RICHARDSON STEWART K; WANG TIANSHENG
权利人:NITROMED INC
摘要:The present invention describes novel nitrosated and/or nitrosylated taxanes, and novel compositions comprising at least one nitrosated and/or nitrosylated taxane, and, optionally, at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The present invention also provides novel compositions comprising at least one taxane and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The compounds and compositions of the present invention can also be bound to a matrix. The present invention also provides methods for treating or preventing cardiovascular diseases and disorders, autoimmune diseases, pathological conditions resulting from abnormal cell proliferation, polycystic kidney disease, inflammatory disease, preserving organs and/or tissues or to inhibit wound contraction, particularly the prophylactic and/or therapeutic treatment of restenosis, by administering nitrosated and/or nitrosylated taxane or parent taxanes in combination with nitric oxide donors that are capable of releasing nitric oxide or indirectly delivering or transferring nitric oxide to targeted sites under physiological conditions.

专利号:US-2003203915-A1
优先权日:2002-04-05
标题 :Nitric oxide donors, compositions and methods of use related applications
发明人：FANG XINQIN; GARVEY DAVID S; GASTON RICKY D; LIN CHIA-EN; RANATUNGA RAMANI R; RICHARDSON STEWART K; WANG TIANSHENG; WANG WEIHENG; WEY SHIOW-JYI
权利人:FANG XINQIN; GARVEY DAVID S; GASTON RICKY D; LIN CHIA-EN; RANATUNGA RAMANI R; RICHARDSON STEWART K; WANG TIANSHENG; WANG WEIHENG; WEY SHIOW-JYI
摘要:The invention describes novel nitric oxide donors and novel compositions comprising at least one nitric oxide donor. The invention also provides novel compositions comprising at least one nitric oxide donor, and, optionally, at least one therapeutic agent. The compounds and compositions of the invention can also be bound to a matrix. The invention also provides methods for treating cardiovascular diseases, for the inhibition of platelet aggregation and platelet adhesion caused by the exposure of blood to a medical device, for treating pathological conditions resulting from abnormal cell proliferation; transplantation rejections, autoimmune, inflammatory, proliferative, hyperproliferative, vascular diseases; for reducing scar tissue or for inhibiting wound contraction, particularly the prophylactic and/or therapeutic treatment of restenosis by administering the nitric oxide donor optionally in combination with at least one therapeutic agent. The invention also provides methods for treating inflammation, pain, fever, gastrointestinal disorders, respiratory disorders and sexual dysfunctions. The nitric oxide donors donate, transfer or release nitric oxide, and/or elevate endogenous levels of endothelium-derived relaxing factor, and/or stimulate endogenous synthesis of nitric oxide and/or are substrates for nitric oxide synthase and are capable of releasing nitric oxide or indirectly delivering or transferring nitric oxide to targeted sites under physiological conditions. The therapeutic agent can optionally be substituted with at least one NO and/or NO 2 group (i.e., nitrosylated and/or nitrosated). The invention also provides novel compositions and kits comprising at least one nitric oxide donor and/or at least one therapeutic agent.